Literature DB >> 27798561

Erratum: Helicobacter pylori exploits human CEACAMs via HopQ for adherence and translocation of CagA.

Verena Königer, Lea Holsten, Ute Harrison, Benjamin Busch, Eva Loell, Qing Zhao, Daniel A Bonsor, Alexandra Roth, Arnaud Kengmo-Tchoupa, Stella I Smith, Susanna Mueller, Eric J Sundberg, Wolfgang Zimmermann, Wolfgang Fischer, Christof R Hauck, Rainer Haas.   

Abstract

Entities:  

Year:  2016        PMID: 27798561     DOI: 10.1038/nmicrobiol.2016.233

Source DB:  PubMed          Journal:  Nat Microbiol        ISSN: 2058-5276            Impact factor:   17.745


× No keyword cloud information.
  4 in total

1.  Inhibition of Type IV Secretion Activity and Growth of Helicobacter pylori by Cisplatin and Other Platinum Complexes.

Authors:  Clara Lettl; Franziska Schindele; Giambattista Testolin; Alexander Bär; Tobias Rehm; Mark Brönstrup; Rainer Schobert; Ursula Bilitewski; Rainer Haas; Wolfgang Fischer
Journal:  Front Cell Infect Microbiol       Date:  2020-12-18       Impact factor: 5.293

2.  Structural basis of the dynamic human CEACAM1 monomer-dimer equilibrium.

Authors:  Amit K Gandhi; Zhen-Yu J Sun; Walter M Kim; Yu-Hwa Huang; Yasuyuki Kondo; Daniel A Bonsor; Eric J Sundberg; Gerhard Wagner; Vijay K Kuchroo; Gregory A Petsko; Richard S Blumberg
Journal:  Commun Biol       Date:  2021-03-19

3.  Fluorophore-conjugated Helicobacter pylori recombinant membrane protein (HopQ) labels primary colon cancer and metastases in orthotopic mouse models by binding CEA-related cell adhesion molecules.

Authors:  Hannah M Hollandsworth; Verena Schmitt; Siamak Amirfakhri; Filemoni Filemoni; Alexej Schmidt; Maréne Landström; Mykola Lyndin; Steffen Backert; Markus Gerhard; Gunther Wennemuth; Robert M Hoffman; Bernhard B Singer; Michael Bouvet
Journal:  Transl Oncol       Date:  2020-08-28       Impact factor: 4.243

Review 4.  Virulence of Helicobacter pylori outer membrane proteins: an updated review.

Authors:  Chenjing Xu; Djaleel Muhammad Soyfoo; Yao Wu; Shunfu Xu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-06-17       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.